Tuesday Market Context:
On Tuesday, the three major U.S. stock indices saw modest gains. The $Dow Jones(.DJI)$ rose by 0.03%, the $S&P 500(.SPX)$ gained 0.16%, and the $NASDAQ(.IXIC)$ increased by 0.46%. The telecommunications services sector performed relatively strongly, rising by 1.5%. In the technology sector, most of the major tech stocks closed higher, with Apple up 1.37%, Microsoft up 0.53%, Amazon up 1.21%, Google-A up 1.72%, and Tesla up 3.50%.
Overview of the 10 Stocks with Market Cap Over $10 Billion Hitting New Highs:
Note: The data in this table is sourced from Tradingview, covering only stocks with a market cap greater than $10 billion and positive year-over-year EPS growth. The data cut-off date is March 25 2025.
In summary:
8 companies were given Buy ratings by analysts: $Royal(RGLD)$ $Fidelity National(FNF)$ $RTX Corp(RTX)$ $Intercontinental Exchange(ICE)$ $Brown & Brown(BRO)$ $Cardinal Health(CAH)$ $Tradeweb Markets Inc.(TW)$ $Unum(UNM)$
1 companies were given Neutral ratings by analysts: $Intra-Cellular Therapies(ITCI)$
7 companies had year-over-year EPS growth exceeding 20%: $Royal(RGLD)$ $Fidelity National(FNF)$ $RTX Corp(RTX)$ $Cardinal Health(CAH)$ $Tradeweb Markets Inc.(TW)$ $Unum(UNM)$ $Intra-Cellular Therapies(ITCI)$
New Highs Analysis:
Based on public data and market information, Tiger Teacher has compiled the core businesses, company highlights, and latest financial data of the 10 companies below. This information is for discussion purposes only and should not be considered investment advice.
Core Business: RTX is a global leader in aerospace and defense, specializing in providing advanced systems and services. Its products include key equipment such as the Patriot missile, NASAM, F-135, F117, and Coyote.
Financial Highlights for Q4 2024: For Q4 2024, RTX reported an adjusted revenue of $2.16 billion, a 9% year-over-year increase, exceeding previous expectations. Adjusted earnings per share (EPS) were $1.54, up 19% year-over-year. The full-year free cash flow is expected to range between $7 billion and $7.5 billion.
2025 Target Price Forecast: Analysts have set the target price for RTX between $120 and $160.
Core Business: ICE is a global leader in operating exchanges and clearinghouses, offering various trading formats such as futures, options, and cash settlement.
Financial Highlights for Q4 2024: Q4 net income was $2.3 billion, up 5%. Adjusted EPS for Q4 was $1.52, up 14%. Full-year net income reached a record $9.3 billion, up 6% (including the acquisition of Black Knight). Full-year adjusted EPS was $6.07, up 8%. Full-year free cash flow was $3.6 billion, with $1 billion returned to shareholders through dividends.
2025 Target Price Forecast: Barclays analyst Benjamin Budish maintains a "Buy" rating on ICE and raised the target price from $167 to $179. Additionally, Raymond James analyst Patrick O'Shaughnessy maintains a "Buy" rating and raised the target price from $130 to $185.
Core Business: Brown & Brown is an insurance agency and brokerage company, mainly providing products and services in areas such as property, accident, and employee benefits insurance.
Financial Highlights for Q4 2024: In Q4 2024, Brown & Brown reported strong performance with EPS of $0.86, exceeding the expected $0.77. The company's revenue exceeded expectations, reaching $1.2 billion, up 15.4% year-over-year, surpassing the expected $1.12 billion. This strong performance is also reflected in an adjusted EBITDAC margin increase of 190 basis points to 32.9%.
2025 Target Price Forecast: Goldman Sachs analyst Robert Cox adjusted the target price for Brown & Brown from $117.00 to $118.00, maintaining a "Buy" rating.
Core Business: Cardinal Health is a healthcare services company, focusing on the distribution of medical products and pharmaceutical solutions.
Financial Highlights for Q4 2024: Cardinal Health's revenue for Q4 increased by 12% to $59.9 billion. In addition, the company’s pharmaceutical and professional solutions departments drove a 9% increase in non-GAAP operating income, reaching $635 million.
2025 Target Price Forecast: Mizuho analyst raised the 2025 fiscal year forecast from $7.90 to $7.95, and the 2026 fiscal year forecast from $8.65 to $8.85. Citi analyst raised the target price from $129 to $130, while Wells Fargo increased the target price from $127 to $135.
Core Business: Tradeweb Markets is a global leader in operating electronic trading platforms, offering services across multiple asset classes including interest rates, credit, money markets, and equities.
Financial Highlights for Q4 2024: For the full year 2024, Tradeweb's total revenue was $1.726 billion, up 29.0% year-over-year. Interest rate products and credit products were the main sources of revenue and both saw significant growth. By the end of 2024, the company had $1.3 billion in cash and cash equivalents, as well as $500 million in unused revolving credit.
2025 Target Price Forecast: Morgan Stanley maintains a "Buy" rating on Tradeweb Markets and raised the target price from $155 to $158. Raymond James also maintains a "Buy" rating and raised the target price from $84 to $133.
Core Business: Loews Corporation is a diversified holding company with business interests in insurance, energy, hospitality, and packaging.
Financial Highlights for Q4 2024: Total revenue for Q4 2024 was $4.55 billion, up 7% year-over-year. The company's overall profitability remained strong, mainly driven by the performance of CNA Financial and Boardwalk Pipelines. By the end of 2024, the book value per share (excluding accumulated other comprehensive income) increased to $88.18.
2025 Target Price Forecast: In a report dated March 19, 2025, Argus raised the target price for Loews Corporation to $95.
Core Business: Fidelity National Financial, Inc. is a leading provider of title insurance, mortgage services, and diversified services.
Financial Highlights for Q4 2024: Q4 EPS reached $1.34, exceeding the expected $1.21. Q4 revenue was $3.62 billion, higher than the expected $3.32 billion. Full-year adjusted net income grew by 31%, reaching $1.3 billion.
2025 Target Price Forecast: Stephens raised the target price from $68 to $75, maintaining an "Overweight" rating. Keefe, Bruyette & Woods raised the target price from $63 to $65, maintaining a "Market Perform" rating.
Core Business: Unum Group is a leading provider of financial protection benefits, with key businesses including group long-term and short-term disability insurance, group life insurance, and supplemental and voluntary products.
Financial Highlights for Q4 2024: For Q4 2024, Unum Group's premium income increased by 3.1% year-over-year to $2.63 billion. Net investment income grew by 2.4% to $543.6 million. Adjusted operating income for the Colonial Life segment surged 39.7% to $122.7 million. The company also announced a new $1 billion stock repurchase plan to begin after the existing buyback program ends in April 2025.
2025 Target Price Forecast: Truist Securities raised the target price from $75 to $90 and maintained a "Buy" rating. BMO Capital Markets raised the target price from $95 to $102 and maintained an "Outperform" rating.
Core Business: Intra-Cellular Therapies, Inc. is a biopharmaceutical company focusing on the treatment of central nervous system (CNS) diseases, with core activities in small molecule drug research and commercialization.
Financial Highlights for Q4 2024: Full-year Caplyta net product sales reached $680.5 million, up 47% year-over-year. Q4 sales were $199.2 million, up 51% year-over-year. Research and development expenses for 2024 were $236.1 million, up 31%; sales, general, and administrative expenses (SG&A) were $504.5 million, up 23%.
2025 Target Price Forecast: Following Johnson & Johnson's announcement of acquiring Intra-Cellular Therapies at $132 per share, several institutions have adjusted their target price to $132 to reflect the acquisition price. Analysts from Mizuho Securities, Canaccord Genuity, RBC Capital Markets, and Piper Sandler have downgraded Intra-Cellular Therapies' rating to "Neutral" or "Hold" and set the target price to $132.
Core Business: Royal Gold, Inc. is focused on precious metals streaming and royalties, securing precious metals or royalties from mining operations through upfront payments.
Financial Highlights for Q4 2024: Q4 revenue was $202.56 million, slightly below the expected $206.01 million. Q4 EPS reached $1.63, surpassing the expected $1.51. Full-year revenue was $719 million, with operating cash flow of $530 million, and net profit increased by 39% to $332 million. The company's gross margin was 86.32%, demonstrating strong profitability.
2025 Target Price Forecast: Raymond James raised the target price for Royal Gold to $188 and maintained an "Outperform" rating, citing the company's strategic positioning and financial health. FactSet's survey indicates a median EPS expectation of $6.30 for Royal Gold in 2025, with a target price forecast of $176.50.
Tigers, which company are you interested in?
Has your stock hit a new high?
Feel free to leave a comment in the discussion area.
Stay tuned. Comment, like and subscribe to @Tiger_Contra
A tool to boost your purchasing power and trading ideas with CashBoost!
Open a CBA today and enjoy access to a trading limit of up to SGD 20,000 with upcoming 0-commission, unlimited trading on SG, HK, and US stocks, as well as ETFs. Find out more here.
Other helpful links:
Comments